{
  "basic_data": [
    {
      "cell_line_alt_name": "FI.SPSM.SCN2A.E1211K.008",
      "cell_type": "iPSC",
      "frozen": "True",
      "hpscreg_name": "FINi003-A"
    }
  ],
  "generator": [
    {
      "group": "The Florey Institute of Neuroscience and Mental Health"
    }
  ],
  "contact": [
    {
      "first_name": "Steven",
      "e_mail": "steven.petrou@florey.edu.au",
      "last_name": "Petrou",
      "group": "The Florey / University of Melbourne"
    }
  ],
  "publications": [
    {
      "last_author": "Steve Petrou",
      "year": "2024.0",
      "first_author": "Dmitry A. Ovchinnikov",
      "doi": "10.1016/j.scr.2024.103367",
      "journal": "Stem Cell Research",
      "title": "An iPSC line (FINi003-A) from a male with late-onset developmental and epileptic encephalopathy caused by a heterozygous p.E1211K variant in the SCN2A gene encoding the voltage-gated sodium channel Na(v)1.2"
    }
  ],
  "donor": [
    {
      "sex": "Male",
      "age": "A5_9",
      "disease_description": "Heterozygous p.E1211K variant in the SCN2A gene causing late-onset developmental and epileptic encephalopathy",
      "disease_name": "Developmental and epileptic encephalopathy (DEE)"
    }
  ],
  "genomic_modifications": [
    {
      "description": "Heterozygous p.E1211K variant in SCN2A (OMIM Allelic Variant: 182390.0009)",
      "loci_name": "SCN2A",
      "genotype": "Heterozygous: SCN2A p.E1211K",
      "mutation_type": "VA"
    }
  ],
  "differentiation_results": [
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "EC",
      "marker_list": "OTX2; PAX6",
      "method_used": "RT-qPCR"
    },
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "EN",
      "marker_list": "SOX17; CXCR4",
      "method_used": "RT-qPCR"
    },
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "ME",
      "marker_list": "TBXT; TBX6",
      "method_used": "RT-qPCR"
    }
  ],
  "genomic_characterisation": [
    {
      "passage_number": "8",
      "karyotype": "46,XY",
      "summary": "High-density SNP array (Illumina Global Screening Array-24 v2.0) on early-passage genomic DNA (p8) showed no detectable loss or gain or loss of heterozygosity across chromosomes; genomic integrity consistent with a normal male karyotype.",
      "karyotype_method": "MKSNP"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_origin_term": "Skin",
      "derivation_year": "2023",
      "non_int_vector_name": "ReproRNA-OK m1 (StemCellTechnologies) polycistronic mRNA (expressing human KLF4 + OCT4/POU5F1 + SOX2 + GLIS1 + c-MYC, plus puromycin N-acetyltransferase protein)",
      "i_source_cell_type_term": "Fibroblasts",
      "non_int_vector": "Other"
    }
  ],
  "ethics": [
    {
      "institutional_HREC": "University of Melbourne Human Research Ethics Committee",
      "ethics_number": "HREC/16/Austin/472"
    }
  ],
  "culture_medium": [
    {
      "passage_method": "EN"
    }
  ]
}